NCT00086203 2015-03-25
Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)
FDA Office of Orphan Products Development
Phase 2 Completed
Clinical Trials
4 trialsNCT00098033 2015-03-25
Investigation of Clofarabine in Acute Leukemias
FDA Office of Orphan Products Development
Phase 2 Completed
NCT00099593 2015-03-25
Immunization Against Tumor Cells in Sezary Syndrome
FDA Office of Orphan Products Development
Phase 2 Completed
NCT00100477 2013-09-25
Use of Topotecan in Patients With Refractory Acute Leukemia
VA Office of Research and Development
Phase 2 Completed